2020
DOI: 10.1016/j.ijcard.2020.03.060
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of Charlson Comorbidity Index in the elderly with a cardioverter defibrillator implantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
12
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 26 publications
3
12
4
Order By: Relevance
“…3) Patients with low comorbidity burden have a similar risk for excess of LOS and mortality as younger patients. Our findings are in line with previous studies that found a higher mortality for patients with a CCI > 1 in elderly patients undergoing implantable cardioverter defibrillator (ICD) implantation and elderly patients that underwent PM implantation [4,5]. We extend these findings to LOS and compared the results of elderly patients to the outcomes of younger patients.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…3) Patients with low comorbidity burden have a similar risk for excess of LOS and mortality as younger patients. Our findings are in line with previous studies that found a higher mortality for patients with a CCI > 1 in elderly patients undergoing implantable cardioverter defibrillator (ICD) implantation and elderly patients that underwent PM implantation [4,5]. We extend these findings to LOS and compared the results of elderly patients to the outcomes of younger patients.…”
Section: Discussionsupporting
confidence: 90%
“…On the other hand, the elderly and extreme elderly are the most rapidly growing segments of the population in developed countries and pacemakers are commonly implanted in this population [4]. However, recent studies suggest that comorbidity may have an equal, if not greater, effect on LOS and mortality as age in a variety of clinical scenarios [5,6]. The objective of this study was to evaluate the impact of comorbidity on LOS and mortality, as compared to age, in patients undergoing new pacemaker implantation.…”
Section: Introductionmentioning
confidence: 99%
“…In this light, it seems rational to examine all SpD patients for mSpD, as there does not appear to be an easy metric for distinguishing between the two groups. Although generally the number and severity of comorbidities are linked to poorer patient outcomes, our data contradict the hypothesis that there is a higher risk of mSpD associated with these factors [18,19].…”
Section: Discussioncontrasting
confidence: 88%
“…In this light, it seems rational to examine all SpD patients for mSpD, as there does not appear to be an easy metric for distinguishing between the two groups. Although generally the number and severity of comorbidities are linked to poorer patient outcomes, our data contradict the hypothesis that there is a higher risk of mSpD associated with these factors (21,22).…”
Section: Discussioncontrasting
confidence: 88%